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Abstract 
We report here on the functional characterization f the H +/peptide cotransporter PEPT 2 cloned from human kidney and on the 
chromosomal localization of the PEPT 2 gene. PEPT 2, when functionally expressed in HeLa cells, induces the transport of the neutral 
dipeptide glycylsarcosine. The induced transport activity is markedly influenced by extracellular pH. The optimum pH for the transport 
process is 6.0-7.0. Kinetic analysis has revealed that PEPT 2 is a high-affinity transporter, the Michaelis-Menten constant for 
glycylsarcosine being 74 _+ 14 /xM. The human intestinal H+/peptide cotransporter PEPT 1 has 4-fold less affinity for the dipeptide 
under identical experimental conditions. Studies with other chemically diverse dipeptides have established that PEPT 2 possesses higher 
affinity than PEPT 1 not only for neutral peptides but also for peptides consisting of anionic and/or cationic amino acids. Somatic ell 
hybrid analysis and in situ hybridization have shown that the gene encoding PEPT 2 maps to human chromosome 3q13.3-q21. 
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The presence of an active mechanism for the reabsorp- 
tion of small peptides in mammalian kidney has been well 
established [1-4]. This system is energized by a transmem- 
brane electrochemical H + gradient [5-7]. Kinetic studies 
have indicated the existence of multiple peptide transport 
systems in the kidney [8-10]. Recent efforts in our labora- 
tory have led to successful cloning of two structurally 
distinct H +/peptide cotransporters, namely PEPT 1 [11,12] 
and PEPT 2 [13]. PEPT 1 was cloned from the intestine. 
This is a low-affinity transporter and is expressed not only 
in the intestine but also in the kidney. This is in agreement 
with previous studies from different laboratories [8-10] 
which have demonstrated the presence of a low-affinity 
peptide transporter in the kidney. PEPT 2 is expressed in 
the kidney but not in the intestine. Our initial studies have 
shown that PEPT 2 exhibits 50% homology in amino acid 
sequence to PEPT 1 [13] and that it catalyzes, like PEPT 1, 
H +-coupled peptide transport. The present paper provides 
evidence that PEPT 2, in contrast o PEPT 1, is a high-af- 
finity transporter. This corroborates earlier findings indi- 
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cating the presence of a high-affinity peptide transport 
system in the kidney [8-10]. The present paper also reports 
on the chromosomal localization of the PEPT 2 gene. 
PEPT 2 was functionally expressed in HeLa cells by 
using the vaccinia virus expression technique [14]. The 
functional characteristics of the expressed transporter were 
studied with respect o the pH-dependence and substrate 
affinity. The pH-dependence of PEPT 2 function was 
investigated by measuring the PEPT 2 cDNA-induced 
glycylsarcosine transport in HeLa cells at various extracel- 
lular pH. The uptake medium of different pH (5.0-9.0) 
was prepared by appropriately mixing two buffers, 25 mM 
Hepes/Tris (pH 9.0) and 25 mM Mes/Tris (pH 5.0), both 
containing 140 mM NaCI, 5.4 mM KC1, 1.8 mM CaCI 2, 
0.8 mM MgSO 4, and 5 mM glucose. Kinetic parameters 
for PEPT 2-mediated glycylsarcosine transport were deter- 
mined by studying the transport rate at varying concentra- 
tions of glycylsarcosine (10-500 /zM). The experimental 
data were fit to a transport model describing a combination 
of a single mediated component and a diffusional compo- 
nent. HeLa cells do not have endogenous peptide transport 
activity [12,13]. The affinity of PEPT 2 for various other 
dipeptides was estimated, according to the method of 
Hajjar and Curran [15], from the potency of these peptides 
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to inhibit the PEPT 2-mediated glycylsarcosine transport, 
assuming competitive interaction between the inhibitory 
peptides and glycylsarcosine. 
Chromosomal localization of the gene coding for PEPT 
2 was accomplished by somatic ell hybrid analysis and by 
in situ hybridization of 3H-labeled PEPT 2 cDNA to 
human metaphase chromosome spreads. A mapping panel 
consisting of mouse-human and Chinese hamster-human 
somatic hybrids (panel no. 1 from the National Institute of 
General Medical Sciences' Human Genetic Mutant Cell 
Repository) was used for somatic cell hybrid analysis. 
DNA was isolated from the hybrid cells, digested with 
EcoRI and the fragments were probed, after size fractiona- 
tion, with 32 P-labeled PEPT 2 cDNA. In situ hybridization 
and emulsion autoradiography were performed as de- 
scribed previously [16,17] by using 3H-labeled PEPT 2 
cDNA as the probe. Chromosomes were G-banded using 
Wright's stain and G-banded chromosomes were analyzed 
for silver grain localization. The cDNA probe was labeled 
by nick translation i  the presence of [ a- 32 P]dCTP (South- 
ern hybridization) or [3H]dCTP and [3H]dTTP (in situ 
hybridization). 
Fig. 1 describes the dependence of glycylsarcosine 
transport in PEPT 2 cDNA-transfected HeLa cells on 
extracellular pH. The transport was very low at pH 9.0, but 
it increased markedly when the pH was decreased. The 
pH-transport ate relationship was bell-shaped in the pH 
range of 5.5-9.0, with an optimum at pH 6.0-7.0. 
Fig. 2 describes the kinetics of glycylsarcosine transport 
in PEPT 2 cDNA-transfected HeLa cells, measured at pH 
6.0. The concentration f the dipeptide was varied over the 
range of 10-500 /zM. The concentration-transport rate
relationship was hyperbolic, indicating saturability of the 
PEPT 2 cDNA-induced transport process. The experimen- 
tal data were found to fit best (r = 0.99) to a transport 
model describing a single carrier-mediated process plus a 
diffusional process. This analysis gave the following val- 
ues for the kinetic parameters of the carrier-mediated 
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Fig. 1. Dependence of PEPT 2-mediated glycylsarcosine transport on 
extracellular pH. HeLa cells were transfected with PEPT 2 cDNA and 12 
h following transfection transport of 30 /~M glycylsarcosine was mea- 
sured with a 3 min incubation at different extracellular pH. Values 
represent means + S.E. for 3 determinations. 
process: K t, 74_  14 /xM and Vma x, 504_ 32 pmol/106 
cells per 3 min. 
These results show that PEPT 2 codes for a high-affin- 
ity H+/peptide cotransporter. The apparent affinity of 
PEPT 2 for glycylsarcosine is 4-fold greater than that of 
PEPT 1 under identical experimental conditions. Glycyl- 
sarcosine is a zwitterionic dipeptide, consisting of neutral 
amino acids. Therefore, it was of interest to know whether 
the relatively higher affinity of PEPT 2 compared to PEPT 
1 is also true for other peptides consisting of anionic 
and/or cationic amino acids. We compared the ability of a 
number of anionic and cationic dipeptides to inhibit the 
transport of glycylsarcosine mediated by PEPT 1 and 
PEPT 2 following their expression i  HeLa cells (Table 1). 
All dipeptides tested inhibited glycylsarcosine transport 
induced by PEPT 1 and PEPT 2. In the case of PEPT 1, 
Table 1 
Inhibition of PEPT 1- and PEPT 2-mediated glycylsarcosine transport by zwitterionic, anionic, and cationic dipeptides 
Inhibitor PEPT 1 PEPT 2 
Gly-Sar transport Estimated Gly-Sar transport Estimated 
K i (/xM) K i (p,M) 
pmol/106 cells per 3 min % pmol/106 cells per 3 min % 
Control 429 + 39 100 - 150 ,1, 8 100 - 
Ala-Ala 196 + 16 46 78 13 ,1, 1 9 6 
Ala-Asp 198 ,1, 18 46 78 34 _ 4 23 18 
Ala-Lys 240 -1- 14 56 117 23 ,1, 4 15 11 
Lys-Ala 352 _+ 20 82 419 43 + 5 28 23 
Asp-Lys 231 ,1, 2 54 108 17 4- 3 12 8 
HeLa cells were transfected with either PEPT 1 cDNA or PEPT 2 cDNA and the transport of glycylsarcosine was measured at pH 6.0 with a 3 min 
incubation. Concentration f Gly-Sar was 25/zM for PEPT 1 and 50 IxM for PEPT 2. Concentration f inhibitory peptides was 100 IzM. Gly-Sar transport 
measured in ceils transfected with empty vector was subtracted from the transport measured in cDNA-transfected cells to determine PEPT 1- or PEPT 
2-mediated transport. K i values were estimated using a K t of 290 /zM for PEPT 1 and 74 /zM for PEPT 2. Values represent means + S.E. for 3 
determinations. 
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Fig. 2. Kinetics of glycylsarcosine transport induced by PEPT 2 cDNA in 
HeLa cells. Transport of glycylsarcosine in PEPT 2 cDNA-transfected 
HeLa cells was measured at pH 6.0 with a 3 min incubation over 
glycylsarcosine concentration range of 10-500 /xM. Values represent 
means _+ S.E. for 3 determinations. Inset: Eadie-Hofstee plot for carrier- 
mediated transport. 
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Fig. 3. Chromosomal location of the PEPT 2 gene. Position and relative 
abundance of silver grains on human chromosome 3 as determined by in 
situ hybridization using [3H]PEPT 2 cDNA as a probe are indicated. 
the transport was measured at a glycylsarcosine concentra- 
tion of 25 /~M. This concentration was less than one-tenth 
of the K t value (290 /zM). The inhibition caused by 100 
/xM of Ala-Asp, Ala-Lys, Lys-Ala and Asp-Lys under 
these conditions ranged between 20 and 55%. The inhibi- 
tion by 100 /xM of the neutral dipeptide Ala-Ala was also 
within this range. In the case of PEPT 2, the transport was 
measured at a glycylsarcosine concentration of 50 /xM. 
This concentration was very close to the K t value (74 
/zM). Under these conditions, the inhibition caused by 100 
~M of Ala-Asp, Ala-Lys, Lys-Ala, Asp-Lys, and Ala-Ala 
was in the range of 70-90%. Using these inhibition data 
and the respective K t values, we estimated the inhibition 
constants (K i) for these peptides according to the method 
of Hajjar and Curran [15]. As shown in Table 1, the K i 
values were in the range of 8-400 ~M for PEPT 1. In 
contrast, the corresponding K i values for PEPT 2 (range, 
6-23 /xM) were manifold lower than those for PEPT 1, 
demonstrating that PEPT 2 exhibits higher affinity than 
PEPT 1 not only for zwitterionic dipeptides but also for 
anionic and cationic dipeptides. 
We have also determined the chromosomal location of 
the PEPT 2 gene. Southern blot hybridization of size-frac- 
tionated EcoRI fragments of DNA from mouse-human 
and Chinese hamster-human somatic cell hybrids using 
the PEPT 2 cDNA probe detected six human-specific 
fragments of 12.5, 6.4, 5.9, 5.5, 1.7, and 1.0 kb, four 
mouse-specific fragments of 11.0, 3.7, 2.4, and 1.3 kb, and 
three Chinese hamster-specific ragments of 13.5, and 2.9, 
and 2.0 kb. All human-specific fragments howed concor- 
dant segregation with human chromosome 3 (Table 2). 
Regional ocalization of the PEPT 2 gene on chromosome 
3 was determined by in situ hybridization of the PEPT 2 
cDNA to human metaphase chromosome spreads. Of 122 
grains from 50 cells scored, 34 (28%) were found at 
chromosome 3q13.3-q21 (Fig. 3). No other chromosomal 
site was labeled above the background level. 
In conclusion, the data presented here clearly establish 
that the cloned human PEPT 2 is a high-affinity 
H+/peptide cotransporter in contrast to the recently cloned 
human PEPT 1 which is a low-affinity H÷/peptide co- 
transporter. The relatively higher affinity of PEPT 2 versus 
Table 2 
Correlation of human sequences detected by PEPT 2 cDNA probe with human chromosomes in rodent X human somatic ell hybrids 
Hybridization/ Human chromosome 
chromosome l 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y 
Concordant + / + 3 4 9 5 4 7 6 7 0 2 1 5 5 8 7 0 9 6 4 5 4 4 0 2 
/ 8 7 8 5 4 4 4 4 8 6 4 4 7 4 5 7 3 7 5 4 5 5 8 7 
Discordant +/ -  6 5 0 2 4 2 2 1 9 3 7 3 3 I 1 8 0 3 4 3 4 4 6 6 
- /+  1 2 0 4 5 5 4 3 1 2 4 5 0 4 2 2 6 2 2 5 4 3 1 1 
Discordant clones 7 7 0 6 9 7 6 4 10 5 11 8 3 5 3 10 6 5 6 8 8 7 7 7 
Informative clones a 18 18 17 16 17 18 16 15 18 13 16 17 15 17 15 17 18 18 15 17 17 16 15 16 
Data for chromosomes involved in rearrangement or present at a frequency of 0.1 or less were excluded. 
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PEPT 1 is seen for a variety of structurally diverse dipep- 
tides. This marked difference in the affinity for peptide 
substrates i the first functional distinction to be reported 
between the cloned human PEPT 1 and human PEPT 2. 
PEPT 2 is expressed in the kidney but not in the small 
intestine. The high-affinity of PEPT 2 for peptides is 
physiologically important because the concentration of the 
peptide substrates in the renal tubular lumen is expected to 
be low. The high-affinity transport system is best suited for 
efficient reabsorption of peptides under these conditions. 
The low-affinity H+/peptide cotransporter PEPT 1 is ex- 
pressed in the intestine and also in the kidney. In the 
intestinal lumen, the concentration f peptides arising from 
the digestion of dietary proteins is expected to be very 
high and therefore the low-affinity/high-capacity transport 
system PEPT 1 is physiologically best suited for absorp- 
tion of the peptides in the intestine. It is of interest that the 
kidney expresses both PEPT 1 and PEPT 2. The brush 
border membrane of the renal tubular cells is one of the 
richest sources of peptidases. It is likely that the concentra- 
tion of small peptides is very low in the early parts of the 
proximal tubule, but the concentration i creases along the 
length of the proximal tubule due to hydrolysis of larger 
peptides and proteins by these peptidases. We speculate 
that PEPT 2 and PEPT 1 may be expressed ifferentially 
in the proximal and distal regions of the proximal tubule, 
respectively, to function most effectively in the reabsorp- 
tion of peptides under these conditions. 
The studies reported here describing the functional dis- 
tinction between PEPT 1 and PEPT 2 in terms of substrate 
affinity are also important for other reasons. In addition to 
endogenous peptide substrates, PEPT 1 and PEPT 2 also 
accept several peptidomimetic drugs as substrates [18-21]. 
It is likely that there are differences between PEPT 1 and 
PEPT 2 in the recognition of these drugs. This might 
indicate that significant quantitative as well as qualitative 
differences exist in the handling of these drugs between 
the intestine which expresses only PEPT 1 and the kidney 
which expresses primarily PEPT 2. In addition, the func- 
tional distinction between PEPT 1 and PEPT 2 in terms of 
substrate affinity may also be very useful in future studies 
directed at identifying the specific domains responsible for 
substrate binding in PEPT 1 and PEPT 2. The chromoso- 
mal localization studies are interesting because of the 
identification of distinct genes encoding PEPT 1 and PEPT 
2. The PEPT 1 gene has been localized to human chromo- 
some 13q33-q34 [13]. The present study has shown that 
the PEPT 2 gene maps to human chromosome 3q 13.3-q21. 
H+-coupled peptide transport across the plasma mem- 
brane has not been described in tissues other than the 
intestine and the kidney. Nonetheless, RNA transcripts 
hybridizing to PEPT 1 cDNA are detectable by Northern 
blot in tissues such as placenta, liver, and pancreas [12]. 
Interestingly, PEPT 2 mRNA is not detectable by Northern 
blot in several of the human tissues tested, including 
kidney [13], suggesting low abundance of the transcript. 
However, evidence has been obtained for the presence of 
the PEPT 2 mRNA in the kidney by using RT-PCR [ 13], a 
method more sensitive than the Northern blot analysis. The 
intestine is negative for the PEPT 2 mRNA even when 
analyzed by this sensitive method. A similar approach as 
not been employed for the detection of the PEPT 2 mRNA 
in other tissues and therefore, it remains to be determined 
whether PEPT 2 is expressed in non-renal tissues. 
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